Please Wait.....
Report
Asia-Pacific Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
Market Report I 2023-01-18 I 220 Pages I The Insight Partners
The APAC immunodiagnostics market is expected to grow from US$ 2,231.31 million in 2022 to US$ 3,587.50 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.
Increasing Prevalence of Infectious Diseases Supports APAC Immunodiagnostics Market Growth
The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are increasing the number of prescriptions for immunodiagnostic tests-complement fixation, precipitation tests, agglutination tests, line blot assays, western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. For instance, according to the World Health Organization (WHO), approximately 58 million people worldwide suffer from chronic hepatitis C infection, with 1.5 million new conditions occurring every year. Approximately 3.2 million adolescents and children suffer from this infection. Diagnostics play a vital role in determining the direction of any medical treatment. Immunodiagnostics help diagnose diseases that severely impact the immune system. All these factors indicate that the rising prevalence of infectious diseases leads to the surging demand for immunodiagnostic products, which is supporting the APAC immunodiagnostics market .
APAC Immunodiagnostics Market Overview
Asia Pacific (APAC) is the fastest-growing market for immunodiagnostics. The APAC immunodiagnostic market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The increasing prevalence of chronic illness in APAC is boosting the demand for diagnostic tests that provide essential details of medical care with detection, diagnostics, and therapy related to the disease. During 2010-2020, APAC witnessed a 39% increase in the number of immunology trials, a significant rise as compared to other regions. In 2020, the maximum number of immunology trials occurred in China, followed by Japan and India. According to Statista, a large chunk of the Chinese population was suffering from chronic diseases in 2020, while in 2019, chronic conditions caused 88.5% of mortalities in the country. The country's geriatric population and the prevalence of chronic illnesses are increasing. Approximately 80% of deaths among the people aged 60 years in the country are caused due to chronic NCDs, of which the most severe are ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and type II diabetes. The incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases (CVDs), and tuberculosis is increasing in the country due to rapid urbanization, which is expected to surge the demand for immunodiagnostic tests.
APAC Immunodiagnostic Market Revenue and Forecast to 2028 (US$ Million)
APAC Immunodiagnostic Market Segmentation
The APAC immunodiagnostic market is segmented into product, clinical indication, end user, and country.
Based on product, the APAC immunodiagnostic market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.
Based on clinical indication, the APAC immunodiagnostic market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. The infectious diseases segment registered the largest market share in 2022.
Based on end user, the APAC immunodiagnostic market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.
Based on country, the APAC immunodiagnostic market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China dominated the market in 2022.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the APAC immunodiagnostic market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Immunodiagnostics Market - By Product
1.3.2 APAC Immunodiagnostics Market - By Clinical Indication
1.3.3 APAC Immunodiagnostics Market - By End User
1.3.4 APAC Immunodiagnostics Market- By Country
2. APAC Immunodiagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Immunodiagnostics Market- Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Immunodiagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Increasing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market- APAC Analysis
6.1 APAC Immunodiagnostics Market Revenue Forecast and Analysis
7. APAC Immunodiagnostics Market Analysis - by Product
7.1 Overview
7.2 APAC Immunodiagnostics Market, By Product, 2021 & 2028 (%)
7.3 Enzyme-linked immunosorbent assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Chemiluminescence immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Immunodiagnostics Market Analysis - Clinical Indication
8.1 Overview
8.2 APAC Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 COVID-19
8.3.3.1 Overview
8.3.3.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Tuberculosis
8.3.4.1 Overview
8.3.4.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Lyme
8.3.5.1 Overview
8.3.5.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.6 Infection Management
8.3.6.1 Overview
8.3.6.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.7 Zika
8.3.7.1 Overview
8.3.7.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.8 Treponema
8.3.8.1 Overview
8.3.8.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.9 TORCH
8.3.9.1 Overview
8.3.9.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.10 Measles and Mumps
8.3.10.1 Overview
8.3.10.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.11 VZV
8.3.11.1 Overview
8.3.11.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.12 EBV
8.3.12.1 Overview
8.3.12.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolics
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Immunodiagnostics Market Analysis - End User
9.1 Overview
9.2 APAC Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Immunodiagnostics Market Revenue and Forecast to 2028- by Country
10.1 Overview
10.1.1 Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 China: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 China Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2.1 China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 China Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 China Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.2 China Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 China: Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.2 Japan: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Japan: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 Japan Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2.1 Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Japan Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 Japan Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.2 Japan Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Japan Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.3 India: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 India: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 India Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2.1 India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 India Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 India Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.2 India Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 India Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.4 Australia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Australia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Australia Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2.1 Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Australia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.1 Australia Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.2 Australia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Australia Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.5 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 South Korea Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2.1 South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 South Korea Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3.1 South Korea Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3.2 South Korea Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 South Korea Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.6 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Asia Pacific Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2.1 Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3.1 Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3.2 Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. APAC Immunodiagnostics Market -Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin S.p.A.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthineers AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 3. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
Table 4. China Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. China Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 6. China Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 7. China Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 11. Japan Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 12. Japan Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 13. Japan Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 14. India Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 15. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 16. India Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. India Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 18. India Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 19. India Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 20. Australia Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 21. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 22. Australia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 23. Australia Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 24. Australia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 25. Australia Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 26. South Korea Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 27. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 28. South Korea Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 29. South Korea Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 30. South Korea Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 31. South Korea Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 38. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 39. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 40. Glossary of Terms, Immunodiagnostics Market
LIST OF FIGURES
Figure 1. APAC Immunodiagnostics Market Segmentation
Figure 2. APAC Immunodiagnostics Market Segmentation, By Country
Figure 3. APAC Immunodiagnostics Market Overview
Figure 4. APAC Immunodiagnostics Market, by Product
Figure 5. APAC Immunodiagnostics Market, by Country
Figure 6. Asia-Pacific PEST Analysis
Figure 7. APAC Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 8. APAC Immunodiagnostics Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. APAC Immunodiagnostics Market, by Product, 2021 & 2028 (%)
Figure 10. Enzyme-linked immunosorbent assays (ELISA): APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Chemiluminescence immunoassays (CLIA): APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Vitamin D Assay: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. HIV Detection: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. HIV Ag/Ab Combo assay: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Other Tests: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Radioimmunoassays (RIA): APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Others: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
Figure 19. Infectious Diseases: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. COVID-19: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Tuberculosis: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Lyme: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Infection Management: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Zika: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Treponema: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. TORCH: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Measles and Mumps: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. VZV: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. EBV: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Hepatitis+HIV: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Gastrointestinal: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Metabolics: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Endocrinology: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Hypertension: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Growth: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Diabetes: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Thyroid: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Reproductive endocrinology: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Others: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. APAC Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
Figure 41. Hospitals: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Clinics: APAC Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Diagnostic Laboratories: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Academic and Research Institutes: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Others: APAC Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Asia Pacific: Immunodiagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 47. Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 48. China: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Japan: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. India: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Australia: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. South Korea: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security